ADVM Stock Earnings: Adverum Biotechnologies Beats EPS for Q4 2023
Source: iQoncept / Shutterstock
Adverum Biotechnologies (NASDAQ:ADVM) just reported results for the fourth quarter of 2023.
- Adverum Biotechnologies reported earnings per share of -23 cents. This was above the analyst estimate for EPS of -34 cents.
- The company did not report any revenue for the quarter.
Article printed from InvestorPlace Media, https://investorplace.com/earning-results/2024/03/advm-stock-earnings-adverum-biotechnologies-for-q4-of-2023/.
©2024 InvestorPlace Media, LLC